Gsk (GSK) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to $35.1 million.
- Gsk's Interest & Investment Income fell 1563.91% to $35.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $241.7 million, marking a year-over-year increase of 2758.59%. This contributed to the annual value of $155.9 million for FY2024, which is 902.54% up from last year.
- Latest data reveals that Gsk reported Interest & Investment Income of $35.1 million as of Q3 2025, which was down 1563.91% from $66.7 million recorded in Q2 2025.
- Over the past 5 years, Gsk's Interest & Investment Income peaked at $77.0 million during Q4 2023, and registered a low of $1.3 million during Q4 2021.
- Its 5-year average for Interest & Investment Income is $34.4 million, with a median of $32.8 million in 2022.
- Per our database at Business Quant, Gsk's Interest & Investment Income plummeted by 8425.78% in 2021 and then soared by 233633.03% in 2022.
- Quarter analysis of 5 years shows Gsk's Interest & Investment Income stood at $1.3 million in 2021, then soared by 2336.33% to $32.8 million in 2022, then skyrocketed by 134.31% to $77.0 million in 2023, then fell by 6.6% to $71.9 million in 2024, then crashed by 51.2% to $35.1 million in 2025.
- Its last three reported values are $35.1 million in Q3 2025, $66.7 million for Q2 2025, and $68.0 million during Q1 2025.